1. Home
  2. RVPH vs FPAY Comparison

RVPH vs FPAY Comparison

Compare RVPH & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • FPAY
  • Stock Information
  • Founded
  • RVPH 2006
  • FPAY 2003
  • Country
  • RVPH United States
  • FPAY United States
  • Employees
  • RVPH N/A
  • FPAY N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • RVPH Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • RVPH 32.8M
  • FPAY 28.7M
  • IPO Year
  • RVPH N/A
  • FPAY N/A
  • Fundamental
  • Price
  • RVPH $0.39
  • FPAY $1.12
  • Analyst Decision
  • RVPH Strong Buy
  • FPAY Strong Buy
  • Analyst Count
  • RVPH 5
  • FPAY 2
  • Target Price
  • RVPH $9.00
  • FPAY $3.25
  • AVG Volume (30 Days)
  • RVPH 2.5M
  • FPAY 51.3K
  • Earning Date
  • RVPH 08-13-2025
  • FPAY 08-05-2025
  • Dividend Yield
  • RVPH N/A
  • FPAY N/A
  • EPS Growth
  • RVPH N/A
  • FPAY N/A
  • EPS
  • RVPH N/A
  • FPAY N/A
  • Revenue
  • RVPH N/A
  • FPAY $139,800,732.00
  • Revenue This Year
  • RVPH N/A
  • FPAY $16.58
  • Revenue Next Year
  • RVPH N/A
  • FPAY N/A
  • P/E Ratio
  • RVPH N/A
  • FPAY N/A
  • Revenue Growth
  • RVPH N/A
  • FPAY 19.51
  • 52 Week Low
  • RVPH $0.30
  • FPAY $0.97
  • 52 Week High
  • RVPH $4.28
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 31.05
  • FPAY 35.76
  • Support Level
  • RVPH $0.30
  • FPAY $1.18
  • Resistance Level
  • RVPH $0.83
  • FPAY $1.24
  • Average True Range (ATR)
  • RVPH 0.07
  • FPAY 0.07
  • MACD
  • RVPH -0.04
  • FPAY -0.01
  • Stochastic Oscillator
  • RVPH 16.04
  • FPAY 0.00

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: